Comparison of Aquaporin -4, -5, -9 and IL-8 Levels in GCF, Dentin Fluid and Pulp Samples
1 other identifier
observational
70
0 countries
N/A
Brief Summary
This study aimed to compare the changes in AQP -4, -5, -9, and IL-8 levels in pulp tissue, GCF, and dentin fluid samples routinely obtained during the treatment of healthy and symptomatic teeth diagnosed with irreversible pulpitis and investigate whether there is a correlation between them. A total of 70 patients aged 18-64 years with healthy (Group 1) and symptomatic irreversible pulpitis (Group 2) diagnosed at Kırıkkale University, Faculty of Dentistry, Department of Endodontics who will undergo routine root canal treatment will be included in the study, with a minimum of 35 participants for each group. Before starting treatment, DOS samples will be taken from healthy, symptomatic, irreversible pulpitis-diagnosed teeth and teeth contralateral to these teeth. A dentin fluid sample will be taken by holding the membrane on the dentin surface, and the pulp tissue will be removed and transferred to Eppendorf tubes. The treatment process will be completed by applying routine root canal procedures to the teeth. The samples' Aquaporin -4, -5, -9, and IL-8 levels will be analyzed by specific enzyme-linked immunosorbent assay (ELISA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2025
CompletedFirst Posted
Study publicly available on registry
April 22, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 12, 2026
ExpectedDecember 1, 2025
August 1, 2025
2 months
April 11, 2025
November 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Aquaporin-4, Aquaporin-5 and Aquaporin-9 expression levels in pulp tissue in dentin fluid and GCF samples
Levels of IL-8, AQP-4, AQP-5 and AQP-9 will be measured in dentin fluid, GCF and pulp tissue samples obtained during routine root canal treatment. The analysis will be performed using ELISA. The aim is to compare the expression levels between healthy individuals and patients with irreversible pulpitis.
Immediately after the procedure
Secondary Outcomes (1)
Correlation analysis between Aquaporin (AQP-4, AQP-5, AQP-9) and IL-8 levels in pulp tissue, dentin fluid, and GCF samples
Immediately after the procedure
Study Arms (2)
healthy pulp group
Minimum 35 participants Procedure: Collection of GCF samples using periopaper. Collection of dentinal fluid using cellulose membrane. Collection of pulp tissue samples using a tirnerf.
irreversible pulp group
Minimum 35 participants Procedure: Collection of GCF samples using periopaper. Collection of dentinal fluid using cellulose membrane. Collection of pulp tissue samples using a tirnerf.
Eligibility Criteria
This study will include patients aged 18-64 years who present to the Department of Endodontics, Faculty of Dentistry, Kırıkkale University, with an indication for root canal therapy and are diagnosed with either a healthy pulp status (Group 1) or symptomatic irreversible pulpitis (Group 2).
You may qualify if:
- Patients aged 18 to 64 years.
- Patients without any known systemic disease.
- Patients requiring root canal treatment for prosthetic purposes (Healthy pulp group).
- Patients with third molars (wisdom teeth) indicated for extraction due to orthodontic or other clinical reasons (Healthy pulp group).
- Patients diagnosed with symptomatic irreversible pulpitis based on the criteria established by the American Association of Endodontists (AAE) (Symptomatic irreversible pulpitis group).
- Patients scheduled for routine root canal treatment at the Department of Endodontics, Faculty of Dentistry, Kırıkkale University.
- Patients who have provided written informed consent to participate in the study.
You may not qualify if:
- Patients with any known systemic disease.
- Pregnant women or those suspected of being pregnant.
- Patients who have used antibiotics, anti-inflammatory drugs, or antidepressants within the past 4 weeks.
- Patients with significant dental plaque or calculus, gingival redness or bleeding, severe gingivitis, generalized periodontitis, or periodontal pockets deeper than 4 mm.
- Patients with teeth showing internal or external root resorption.
- Patients for whom complete rubber dam isolation cannot be achieved.
- Patients with teeth exhibiting signs of necrosis, apical lesions, swelling, or presence of a sinus tract.
- Patients with immature teeth presenting open apices.
- Patients with third molars (wisdom teeth) that are not fully erupted or have been previously diagnosed with pericoronitis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
TANSU M BEŞPARMAK, PhD student
Kirikkale University, Faculty of Dentistry
- STUDY CHAIR
ALİ ERDEMİR, PROF
Kirikkale University, Faculty of Dentistry
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor doctor
Study Record Dates
First Submitted
April 11, 2025
First Posted
April 22, 2025
Study Start
December 1, 2025
Primary Completion
February 1, 2026
Study Completion (Estimated)
September 12, 2026
Last Updated
December 1, 2025
Record last verified: 2025-08